These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22038362)

  • 1. Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma.
    Zhang M; Li T; Chen J; Li L; Zhou C; Wang Y; Liu W; Zhang Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):687. PubMed ID: 22038362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
    Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
    Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach.
    Tong YK; Jin S; Chiu RW; Ding C; Chan KC; Leung TY; Yu L; Lau TK; Lo YM
    Clin Chem; 2010 Jan; 56(1):90-8. PubMed ID: 19850629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21.
    Chim SS; Jin S; Lee TY; Lun FM; Lee WS; Chan LY; Jin Y; Yang N; Tong YK; Leung TY; Lau TK; Ding C; Chiu RW; Lo YM
    Clin Chem; 2008 Mar; 54(3):500-11. PubMed ID: 18202156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Differentially Methylated Loci in Clinical Diagnosis of Trisomy 21 Syndrome.
    Zhang R; Yin Y; Zhang S; Chen L; Pu L; Deng Q; Zhang H; Xiao L
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):246-250. PubMed ID: 30986102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density.
    Lim JH; Lee DE; Kim KS; Kim HJ; Lee BY; Park SY; Ahn HK; Lee SW; Kim MY; Ryu HM
    Clin Chem Lab Med; 2014 May; 52(5):641-7. PubMed ID: 24353143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome.
    Tsui DW; Lam YM; Lee WS; Leung TY; Lau TK; Lau ET; Tang MH; Akolekar R; Nicolaides KH; Chiu RW; Lo YM; Chim SS
    PLoS One; 2010 Nov; 5(11):e15069. PubMed ID: 21152411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma.
    Ou X; Wang H; Qu D; Chen Y; Gao J; Sun H
    Transfusion; 2014 Oct; 54(10):2523-33. PubMed ID: 24749853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations.
    Tong YK; Ding C; Chiu RW; Gerovassili A; Chim SS; Leung TY; Leung TN; Lau TK; Nicolaides KH; Lo YM
    Clin Chem; 2006 Dec; 52(12):2194-202. PubMed ID: 17040955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Changes of Fetal-Derived Hypermethylated RASSF1A and Septin 9 Sequences in Maternal Plasma.
    Zhang L; Wang CM; Zhou WP; Chen QP; Zhou S; Lei W; Deng H; Zhang L; Liu GC
    Reprod Sci; 2021 Apr; 28(4):1194-1199. PubMed ID: 33417202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome.
    Old RW; Crea F; Puszyk W; Hultén MA
    Reprod Biomed Online; 2007 Aug; 15(2):227-35. PubMed ID: 17697502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker.
    Tong YK; Chiu RW; Akolekar R; Leung TY; Lau TK; Nicolaides KH; Lo YM
    PLoS One; 2010 Dec; 5(12):e15244. PubMed ID: 21249119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.
    Zejskova L; Jancuskova T; Kotlabova K; Doucha J; Hromadnikova I
    Exp Mol Pathol; 2010 Dec; 89(3):241-7. PubMed ID: 20868679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.
    Lee DE; Lim JH; Kim MH; Park SY; Ryu HM
    J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.
    van den Oever JM; Balkassmi S; Segboer T; Verweij EJ; van der Velden PA; Oepkes D; Bakker E; Boon EM
    PLoS One; 2013; 8(12):e84051. PubMed ID: 24391879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21.
    Lim JH; Lee DE; Park SY; Kim DJ; Ahn HK; Han YJ; Kim MY; Ryu HM
    BMC Med Genomics; 2014 Jan; 7():1. PubMed ID: 24397966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
    Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
    Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies.
    Papageorgiou EA; Fiegler H; Rakyan V; Beck S; Hulten M; Lamnissou K; Carter NP; Patsalis PC
    Am J Pathol; 2009 May; 174(5):1609-18. PubMed ID: 19349366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive value of placenta-derived RASSF1A sequence expression in maternal plasma for pre-eclampsia].
    Wang J; Yang J; Wu X; Mu Y; Li S; Cui K; Wang X; Zhao F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):25-8. PubMed ID: 24510557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
    Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
    Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.